• Edwards Lifesciences EPS for the quarter ending December 31, 2024 was $0.65, a 6.56% increase year-over-year.
• Edwards Lifesciences 2024 annual EPS was $6.97, a 203.04% increase from 2023.
• Edwards Lifesciences 2023 annual EPS was $2.3, a 5.74% decline from 2022.
• Edwards Lifesciences 2022 annual EPS was $2.44, a 2.52% increase from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.